[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FDA questions Rexulti's efficacy, while Praxis receives Breakthrough Therapy Designation for relutrigine. Investors are watching for the impact on $HLBBF.
Summary of social media activity related to the stock ticker $hlbbf.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +5.40%
1 Month: XXXXX +600%
1-Year High: XXXXX on 2025-07-18
1-Year Low: X on 2025-05-01
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +50%
1 Month: X +150%
1-Year High: X on 2025-05-03
1-Year Low: X on 2025-04-29
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $hlbbf in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +100%
1 Month: X +200%
1-Year High: X on 2025-07-10
1-Year Low: X on 2025-04-29
Top assets mentioned In the posts about $hlbbf in the last XX hours
Top topics mentioned In the posts about $hlbbf in the last XX hours
$ucbjf, $biib, $aqst, nyc, investment, combo, $4768t, $4578t, $otsky
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$OTSKY $HLBBF - Otsuka Lundbeck Fail To Sway Adcomm on Rexulti Combo for PTSD -"
@MarcJacksonLA on X 2025-07-21 14:55:51 UTC 7095 followers, XXX engagements